Abstract
Background: Transgender women are disproportionately affected by HIV in the United States. Evidence shows that HIV self-testing increases awareness of HIV status, preventing transmission. Culturally appropriate strategies are needed to provide HIV self-tests (HIVSTs) to transgender women.
Objective: This paper aims to describe an adaptation for transgender women of a comparative effectiveness trial of an intervention (Know@Home website) on the use of HIVSTs, counseling, and linkage of participants to appropriate services initially designed to reach Black or African American and Hispanic or Latino men who have sex with men (Implementation of Rapid HIV Self-Testing Among MSM Project).
Methods: The ADAPT-ITT (Assessment, Decision, Adaptation, Production, Topical Experts, Integration, Training, and Testing) framework guided the adaptation. Project staff worked with consultants and a community advisory board to revise all study materials (ie, intervention web content, marketing text and images, and language used in the surveys) to be tailored to, and inclusive of, health topics relevant to transgender women. We conducted a pilot study with transgender women recruited through online venues. Participants were randomly assigned 2:1 to the intervention arm or control arm. All participants were mailed 2 HIVSTs, the OraQuick In-Home HIV Test, and had access to a standard resource list including information on how to find a nearby testing location, HIV prevention, and sexual health. Only intervention arm participants had access to the study website, “Know@Home.org.” The Know@Home website allowed participants in the intervention arm to order sexually transmitted infection test kits, condoms, and lubricant and provided HIV prevention information, service locators, and risk assessment tools. Adaptations to the intervention included modifying language, images, and links to outside resources to be transgender specific or gender neutral. Online surveys were adapted by removing inappropriate gender terms and replacing them with culturally appropriate terms for gender identity, genitalia, and condom use. Four months after completing the baseline (enrollment) survey, all participants were asked to complete a final follow-up survey. Upon completing the 4-month survey, participants were mailed a dried blood spot collection kit to be returned by mail for the laboratory testing of the sample. The results of all HIVSTs could be reported in real time in an online survey. Video health counseling was available, upon request, for all participants during study participation.
Results: Enrollment into the pilot study began on April 22, 2021, and concluded on July 7, 2021, yielding a total of 102 transgender women participants, with data collection completed in January 2022.
Conclusions: By using the ADAPT-ITT model, we produced materials to be culturally and linguistically appropriate for transgender women. The findings of this study have the potential to inform future research studies among transgender women and underscore the importance of involving subject matter experts and community members in the development of tailored materials.
Trial Registration: ClinicalTrials.gov NCT04219878; https://clinicaltrials.gov/study/NCT04219878
International Registered Report Identifier (IRRID): PRR1-10.2196/75345
doi:10.2196/75345
Keywords
Introduction
The Ending the HIV Epidemic in the United States initiative is built on 4 science-based strategies. The first is diagnosing all individuals with HIV as early as possible. HIV testing allows people to learn their HIV status and initiate pre-exposure prophylaxis (PrEP) or antiretroviral treatment, preventing new infections. HIV self-testing (HIVST) is one component of this testing strategy [-].
In 2019, approximately 2% of HIV infection diagnoses were among transgender persons. The majority (93%) of these were among transgender women []. Transgender women in the United States are disproportionately affected by HIV with a prevalence of 14.1%, compared with an estimate of less than 0.5% for all US adults [-].
The underutilization of HIV testing may contribute to the disproportionate impact of HIV among transgender women [], as HIV testing is the entry to engagement with HIV prevention and treatment []. A study in the United Kingdom found that transgender people are less likely to have ever tested for HIV than cisgender people (49% vs 64%, respectively) []. Barriers to HIV testing reported by transgender women include low risk perception, lack of access to HIV testing, and concerns of HIV-related stigma and transphobia in health care settings [-]. Providing HIVSTs to transgender women may reduce some barriers they experience when seeking gender-affirming HIV testing services by expanding routine testing options and partially mitigating the barrier of medical mistrust [,-]. Self-testing allows users the flexibility of not having to present to clinical or community-based testing sites where providers may not be culturally competent. This testing approach provides an alternative to those who are distrustful of medical settings, who want to avoid settings that could trigger gender dysphoria, or who do not wish to be seen attending testing sites, due to stigma, discrimination, homophobia, transphobia, and racism [,].
Many studies conflate cisgender men who have sex with men (MSM) with transgender women, and the studies that disaggregate data on transgender women are limited [,]. Tailoring existing interventions is an important strategy to expedite the creation and deployment of effective interventions and improve public health outcomes for targeted populations [,,]. Preliminary evidence indicates that technology-based behavioral health interventions, such as using social media, have the potential to promote HIV testing and decrease prevention disparities []. Social media–based interventions can increase engagement in care [], and computerized counseling and text-based interventions can improve viral suppression among transgender women [-], although some studies did not show statistically significant results, and more research is needed [].
This paper presents the adaptation of the study protocol and materials from the Implementation of Rapid HIV Self-Testing Among MSM Project (iSTAMP) [] for use with transgender women. The iSTAMP study evaluated strategies to reach participants for distributing HIVST and incorporated a pilot evaluation of an HIV prevention phone app to improve linkage to HIV prevention and care designed for Black and Hispanic MSM []. Mailing HIVSTs to gay, bisexual, and other MSM increased rates of testing and awareness of infection status. An adaptation of the original protocol for transgender women was necessary to consider social and behavioral characteristics unique to this population.
Through an existing cooperative agreement with the Centers for Disease Control and Prevention, we obtained funds for conducting pilot activities for transgender women. This pilot project was funded separately from the original iSTAMP study at the end of year 3 of the 4-year project period.
The study aimed to evaluate (1) the comparative effectiveness of the intervention (Know@Home website) on the use of HIVSTs, counseling, and linkage of participants to appropriate services (ie, HIV treatment, HIV PrEP, sexually transmitted infection [STI] testing, additional prevention, and social services) and (2) the cost of implementing recruitment strategies and the intervention. We describe a community-engaged process to adapt the iSTAMP protocol to be culturally appropriate for transgender women, which included adapting recruitment materials, survey tools, and the interactive intervention website.
Methods
Overview
This pilot study assessed whether the iSTAMP protocol, online advertisements, and recruitment materials [], originally designed for recruiting and engaging Black and Hispanic MSM, could be adapted for and implemented for transgender women. Most study procedures were the same as those described in the iSTAMP protocol paper []. Briefly, the iSTAMP randomized control trials (both the original study and this adaptation) were designed to evaluate a program that distributed HIVST kits. The iSTAMP included a nested randomized component assessing the utility of comprehensive prevention content (Know@Home []) to support related HIV prevention services for those assigned only to the intervention arm. The adaptation substituted the Know@Home mobile app for a website named Know@Home with similar materials tailored to transgender women. The intervention content included HIV prevention information; a way to order condoms and STI self-collection kits; risk assessment tools; and locators for HIV testing, HIV treatment, and PrEP services. Four months after completing the baseline (enrollment) survey, all participants were asked to complete a final follow-up survey, which collected information on sexual behavior, HIV testing and status, and linkage to care. Upon completing the 4-month survey, participants were mailed a dried blood spot collection kit to be returned by mail for laboratory testing. The results of all HIVSTs could be reported in real time into an online survey. Video health counseling was available, upon request, for all participants during study participation. Further details about study design, participant flow, data collection, and planned analyses can be found in the original iSTAMP protocol paper [].
This paper focuses on materials affecting the transgender participant, rather than internal staff documents, such as standard operating procedures and email, text, or phone scripts. Electronic case report forms captured enrollment and retention, HIVST result follow-up communications, referrals, and video counseling.
Our adaptation was guided by the 8 phases of the ADAPT-ITT (Assessment, Decision, Adaptation, Production, Topical Experts, Integration, Training, and Testing) model [] (). We chose the iSTAMP study for assessment, reviewed literature, identified domains of the study for adaptation, and developed a list of needed adaptations. Topical experts provided input on marketing and recruitment materials and recommended changes to intervention materials and survey assessments. Suggested changes were integrated into all study materials. The testing phase of the pilot study and associated data analyses occurred as the final phase.
| Phase | Staff roles | Activity | Outcomes |
| Assessment |
|
|
|
| Decision |
|
|
|
| Adaptation |
|
|
|
| Production |
|
|
|
| Topical experts |
|
|
|
| Integration |
|
|
|
| Training or testing |
|
|
|
aiSTAMP: Implementation of Rapid HIV Self-Testing Among MSM Project.
Assessment
In the assessment phase, we reviewed relevant literature and decided to adapt an intervention to promote HIV self-testing to increase HIV testing and awareness of HIV status for transgender women. An informal literature review indicated that transgender women were disproportionately affected by HIV [,,]. Transgender women’s unique experiences and their desire for HIV interventions and services necessitated specialized research to assess risks that differentiate transgender women from MSM [,].
The literature review indicated that additional behavioral health survey items, which are not typically included in HIV research with MSM, for example, gender identity and hormone replacement therapy, would be relevant for transgender women. These items were chosen and included in the survey tool. Research staff determined their capacity to adapt and implement the HIV counseling and referral component of the study and assessed the availability of transgender-specific referral resources for HIV testing and prevention services.
Decision and Adaptation
In the decision phase, we selected the iSTAMP study because the distribution of HIV self-test kits has shown to increase HIV testing in MSM [], and there were specifically designed materials and processes available that could be adapted.
In the adaptation phase, although many aspects of the original iSTAMP study protocol remained the same (eg, OraQuick In-Home HIV test, the recruitment, and mailing systems), several domains required revision, including the recruitment materials (images and text), survey questions, and an intervention website. In March 2020, 5 members of the community and several culturally competent iSTAMP study staff identified language in existing survey materials that was not culturally appropriate for transgender women. They provided alternative appropriate language. A US $50 gift card was provided for the community members’ time.
Production
During the production phase, staff reviewed the relevant literature from the assessment phase and created a list of required changes. This was a preliminary list of potential adaptations required to tailor the iSTAMP study for transgender women.
Topical Experts: Recruitment and Advertising Materials
Study staff convened an online meeting of consultants to identify effective recruitment strategies and tailor advertising materials specifically for transgender women. Consultants were either transgender women, transfeminine-identifying individuals, or nonbinary-identifying individuals. We recruited the consultants through social media and flyers sent to lesbian, gay, bisexual, transgender, and queer organizations located in the 11 states from which we planned to recruit participants. Each consultant was provided a US $50 e-gift card for their time. Four consultants participated in a recorded, online videoconference held in November 2020.
The consultants discussed the suitability of recruiting transgender women from online dating websites and social media platforms and explored potential platforms that may have had a greater transgender women user base than those already under consideration, such as TikTok. The facilitator presented the examples of advertising images and text messages to assess cultural acceptability.
Consultants identified that the pop cultural references used in the original intervention were more relevant to MSM and the drag community than to transgender women. The examples included language such as “Demon time” that references horniness and “Faster than beating your mug” that references applying makeup. The use of drag references with transgender women was deemed by the consultants to be offensive and inappropriate.
The language that alluded to using sex-seeking apps (eg, “You host, we’re mobile” appearing to reference the dating app Grindr, or “Plan for your fans” appearing to reference the website OnlyFans, which is often used by sex workers) was viewed negatively by consultants. The consultants stated that the transgender women’s community has often been portrayed as hypersexualized within mainstream media and that these text messages and images reinforced the stereotype. Advertisement text that focused on respecting transgender identities and intimated themes of empowerment was preferred.
Consultants emphasized the importance of using photographs with transgender women. Images where the individual’s transgender or gender nonconforming identity was more prominent were rated higher. Consultants stated that text specifically used to provide assurances of data security or confidentiality (eg, “Your identity is safe here”) increased the skepticism of data protections and how participant information may be used. Another identity-related concern the consultants discussed was that the study should consider developing procedures to allow participants to use different names in different contexts. For example, some participants may prefer to use their legal name or “deadname” at home because they are not “out.” They reported that participants might want to use a chosen name on email and text communications but use their legal name or “deadname” on postal packages to avoid disclosing their transgender identity to the people with whom they live.
There was a consensus among consultants that obtaining free HIVSTs and STI home collection kits would be viewed as beneficial by transgender women. Consultants also agreed that the financial token of appreciation for the participant’s time should be included in the advertisement because it may be viewed by many potential participants as immediately beneficial. and provide examples of recruitment advertisements that resulted in greater response from potential participants during the study. All advertisements were created using licensed stock photos.


Topical Experts: Intervention Website
In this pilot study, we substituted the Know@Home mobile app, provided for the MSM intervention arm of the original iSTAMP trial, for a website named Know@Home, which included the same materials adapted for transgender women. The website contained HIV prevention information and allowed participants to order free materials (eg, condoms and STI self-collection kits) and access online risk assessment tools and service locators for HIV testing, HIV treatment, and PrEP services.
A subject matter expert (SME) on transgender health reviewed the Know@Home website intervention content and supporting materials. The expert proposed revisions to make the content suitable for transgender women based on recommendations from the Provincial Health Services Authority of British Columbia [], which was a reliable source for recommendations at the time of study design. The reviewed intervention sections included written and video messaging components, risk-assessment quizzes to help assess one’s risk for HIV infection, embedded links to external pages, and the static informational pages consisting of the “About Us” page and STI and HIV information.
Materials were revised with the gender-neutral terms “person” and “people.” Materials that directly referred to sexual anatomy were revised to use gender-neutral anatomical terms []. Video messages and external links to study materials were reviewed, and those appropriate for MSM were replaced with gender-neutral alternatives. Content that featured only MSM was replaced with content that featured transgender women or images that would be appropriate for all audiences regardless of gender identity. lists the 4 core themes identified as requiring revisions and examples of appropriate terminology replacements. The four core themes included: (1) gendered terminology referring to the participant, (2) gendered terminology referring to the participant’s sex partners, (3) terminology describing genitalia and sexual acts, and (4) condom use.
| Theme identified | iSTAMP terms and phrases | Revised terms and phrases | Reasons text modified | Study materials updated |
| Participant gender identity |
|
|
|
|
| Sex partner or partners gender identity |
|
|
|
|
| Terms describing genitalia and sex acts |
|
|
|
|
aMSM: men who have sex with men.
Topical Experts: Survey Assessments
An SME on transgender health reviewed the online surveys and identified items that needed to be rephrased with culturally appropriate terminology based on current best practices []. The SME identified and recommended survey domains that were relevant to transgender health that were not included in the original surveys designed for MSM.
Similar to the intervention materials, baseline and follow-up surveys were revised to ensure clarity and appropriateness of questions pertaining to the gender, sex, and genitalia of respondents and their sexual partner or partners. Questions were removed if they fell within the 4 core themes identified as inappropriate for transgender women. Supplemental questions related to the experiences of transgender women were developed using appropriate terminology for transgender women. These questions were provided to participants directly after they completed the baseline and follow-up surveys.
The supplemental questions obtained data on the following domains: gender identity, sexual orientation, gender presentation, mental health and suicidality, sexual behavior (using affirming language for genitalia), gender confirmation surgeries, hormone replacement therapy, electrolysis, hormonal and medical gender affirmation, gender-based stigma, and history of intimate partner violence. For transgender-specific intimate partner violence, we used the Peitzmeier Transgender-Specific Intimate Partner Violence scale, which is tailored for transgender women and consists of four domains: (1) coercive control of gender transition or gender presentation, (2) emphasizing the undesirability of transgender individuals as intimate partners, (3) blackmail via “outing,” and (4) sabotaging transition []. This tool has demonstrated adequate internal consistency (KR-20=0.56) []. To measure gender-based stigma, we used a 13-question scale developed by Maksut et al [] that assessed perceived, anticipated, and enacted stigmas due to gender identity. This gender identity stigma scale has demonstrated acceptable internal consistency (Cronbach 𝑥=0.79) [].
Integration and Testing
Project staff, the principal investigators, and SMEs reviewed and approved each adaptation. With the deployment of the redesigned website and the implementation of the revised materials for transgender women, we conducted a randomized control trial in which we aimed to recruit up to 200 participants. The eligibility criteria are described in .
Eligibility criteria
- Provided informed consent online
- At least 18 years of age
- Identifies as a transgender woman or transgender female
- Assigned male sex at birth
- Has an Android or iOS mobile smartphone with active service
- Resides in Alabama, California, Florida, Georgia, Louisiana, Mississippi, North Carolina, Nevada, New York, South Carolina, and Texas
- Provides valid contact information
- Successfully completed the baseline survey
Exclusion criteria
- Declined consent to participate
- Currently participating in another HIV prevention research study or program
- Has a bleeding disorder
- Participant in an HIV vaccine study
- Currently taking pre-exposure prophylaxis for HIV prevention
- Reported a prior positive HIV test result
- Plans to move out of a study state during the 4 months study period
The goal of the pilot study was to provide preliminary data on recruiting transgender women online and the feasibility of enrolling transgender women into an HIV self-testing study. The data collected provide estimates for the length of time needed to recruit participants, the effectiveness of online recruitment strategies, the cost of recruitment, retention rates, the use and acceptability of video counseling services, and the proportion of transgender women who reported using the HIVSTs and STI self-collection kits. These data will be used in conducting power calculations for future HIV self-testing research studies with transgender women.
We planned to use the data to identify key considerations for programmatic implementation of a mail-out HIV self-testing program for transgender women that could be implemented by local health departments or community-based service providers. Factors that are relevant for implementation by these providers include online recruitment and costs to implement.
For this pilot study, potential participants were recruited through online venues, such as social networking sites (eg, Facebook) and dating apps (eg, Jack’d), which were chosen using advertising data from the previous recruitment of transgender women. Participants completed an initial eligibility screening survey, provided electronic informed consent, and completed a baseline survey. An initial validation process was conducted to determine enrollment status. Participants were considered fully enrolled in the study and mailed 2 HIVSTs after they had provided the required contact information, and duplicate accounts were excluded.
We used a two-stage stratified randomization procedure []. First, we grouped participants based on race or ethnicity (Black, White, Other, Hispanic or Latina) for a total of 4 strata. Next, we randomly assigned participants from each strata to the intervention arm (mailed self-test kit+provided link to the Know@Home website) or control arm (mailed self-test kit only) with a 2:1 ratio.
Ethical Considerations
This pilot study was approved by the Emory University Institutional Review Board (IRB00099710) and is registered at ClinicalTrials.gov (NCT04219878). Personal identifying information was only stored at Emory University. Confidential information was stored off site on secure web servers. All data files were encrypted with strong password protection. Access to personally identifying information was restricted to Emory study staff. Informed consent was acquired online. Incentives in the form of e-gift cards were provided to participants for completing various study activities totaling up to US $70 over the 4-month study period. Additional optional surveys allowed participants to earn an additional US $60.
Results
The main research outcomes from this pilot study are summarized in . During the enrollment period, from April 22, 2021, to July 7, 2021, a total of 2014 people consented to be screened for the study, most of whom were ineligible for multiple reasons. Not identifying as female or a transgender woman was the most common reason for ineligibility. Of 217 people who were eligible based on screening criteria, 169 provided contact information. Of these, 108 participants passed the initial validation process, responded to a text message to complete the validation process, and completed the baseline survey. Subsequently, we determined that an additional 6 people had provided false information (eg, they revealed that they did not identify as transgender women) and were excluded from the analyses. A total of 102 transgender women constituted the sample for this pilot study, and 81 provided follow-up information. In total, 20 participants (18%) were non-Hispanic Black, 49 (48%) were non-Hispanic White, 18 (17%) were Hispanic or Latina of any race, and 15 (14%) were of another race.
| Research outcomes | Types of data | Relevance to study design |
| Feedback on sample advertisements |
|
|
| Proposed recruitment strategies for transgender women (specific online sites, influencers, advertisement images, language) |
|
|
| Feasibility of online enrollment of transgender women |
|
|
| Time to recruit |
|
|
| Retention rates |
|
|
| Percent of participants using study HIVST |
|
|
| HIV prevalence among pilot study participants |
|
|
| Percent of participants using video counseling services |
|
|
aHIVST: HIV self-testing.
Discussion
Principal Findings
This paper documents the process of adapting the iSTAMP protocol developed for Black and Hispanic MSM to be appropriate for engaging transgender women, using the 8-phase ADAPT-ITT model. The purpose of this adaptation is to ensure that study procedures and materials presented to participants are culturally and linguistically appropriate and do not cause discomfort or harm. In our adaptation process, we strove to ensure that study materials would not misgender participants and that questions and responses would be culturally relevant and inclusive [,]. These adaptations were crucial to ensure the data obtained were relevant for transgender women who participated in the study and would allow us to gain a comprehensive understanding of the experiences of transgender women. Other adaptation studies reflected the importance of including content related to gender dysphoria, police or law enforcement interactions, HIV testing, PrEP, and antiretroviral treatment as well as reflections of transgender women in the study materials []. Several studies used focus groups or community advisory boards, including transgender members [-]. Some studies noted the importance of including transgender women at any stage of transition as well as nonbinary individuals [,]. The resources developed in this protocol can be used to provide preliminary data and tools for further development and evaluation of a robust trial HIVST distribution and linkage to prevention services for transgender women in the United States.
Limitations
We encountered several challenges during the development and implementation of this pilot study. This activity was conducted after the completion of a trial for MSM with supplemental funding awarded in the final year of the original study. Consequently, the achieved sample size was half of what was originally planned because there were time constraints in which all activities had to be completed, leading to potential limitations around the ability to assess feasibility. Sample representativeness is limited by sampling technique and sample size.
Only 4 of the 9 consultants were able to participate in the online videoconference due to scheduling conflicts, limiting the input on the adaptation process; however, written feedback was elicited from all 9 consultants, and we had coauthors who are SMEs who contributed to the adaptation. The study was conducted in 11 US states, predominantly located in jurisdictions with a high prevalence of HIV in the United States. The sample does not represent all transgender women in the United States.
Due to time constraints, we created a web-based version of the original intervention developed for use on a mobile phone. We used the same eligibility screener questions from the MSM trial due to timeline constraints, and participants were required to identify as “male to female transgender.” This language may have discouraged some transgender women from participating in the study if they did not identify with this terminology. To earn trust among the community, it is necessary to use appropriate language [], and future studies can incorporate an expanded eligibility criterion to include transgender women who may identify with alternative terminologies, such as transgender woman, transfeminine, or other terms that are commonly used at the time of study implementation.
This study examines a mobile intervention, which is accessible to people with smartphones. Additionally, nearly half of the study population is non-Hispanic White. Although over 91% of the US population owns a smartphone [] and over half the US population is non-Hispanic White, these factors could have led to an underrepresentation of groups bearing a high HIV burden among transgender women.
Future Adaptations
During the adaptation process, we identified several key principles that may be useful for future adaptations of protocols or interventions for transgender women. When collecting names and pronouns, researchers can inform participants that legal names may not be required to participate, and when possible, collect both the legal name and the name the participant wishes to use during study participation. Engaging members and representatives of the community in planning the research design and materials can mitigate cultural competency issues when tailoring materials. Involving SMEs on transgender women, particularly when the experts are a part of the intended study population, in planning the research design and materials for future studies for transgender women could allow studies to be culturally appropriate [-].
Mixed methods approaches provide an opportunity for increasing cultural competency of materials and survey instruments. Qualitative methods can be used to allow transgender women to provide detailed feedback on materials and terminology before implementation. Validating survey instruments that were designed for other populations as well as formal A or B testing would improve recruitment optimization and study rigor.
Linguistic choices that pathologize or marginalize people are potentially harmful to participants during the research and publication of findings [,]. As languages and cultures evolve, it is necessary to adapt terminology so that terms are culturally appropriate for the proposed populations. This may require modifying demographic terminology () used to collect data to reflect the culture of the population. Finally, while this pilot study engaged transgender women, future studies could widen inclusion criteria to include other populations who may also benefit from HIV self-test programs, such as nonbinary people, gender-nonconforming people, transgender men, and transmasculine people.
Conclusions
We adapted study materials for an HIV prevention intervention for transgender women. By using the ADAPT-ITT model, we systematically produced materials that are culturally and linguistically appropriate for transgender women. The research process and resulting materials have the potential to inform future research studies among transgender women and underscore the importance of involving SMEs and community members in the development of tailored materials.
Acknowledgments
We thank the study consultants and participants for providing valuable information and participation and Susie P Danner for her review of the paper.
Funding
This study was funded through the CDC Cooperative Agreement #U01PS005181 to Emory University and with supplemental funds from the Minority HIV/AIDS Fund. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Data Availability
After the primary outcome analyses are completed, deidentified datasets can be made available upon written request to the investigator PSS. Interested parties should propose a specific analytic hypothesis. The data use agreement would be developed to ensure that (1) data are used solely for research purposes without attempting to identify individual participants, (2) there is a clear plan for maintaining the safety and security of the data, and (3) commitment to the destruction or return of the data after analysis.
Authors' Contributions
JAC, RD, PSS, and SS conceptualized, wrote, reviewed, and edited the paper. EO and ILL conceptualized, reviewed, and edited the paper. MH contributed to data curation. TS, LH-W, and AS conceptualized and reviewed the paper. All authors contributed to the investigation.
Conflicts of Interest
TS is the editor in chief of JMIR Public Health and Surveillance. The other authors declare no conflicts of interest.
References
- EHE overview. HIV.gov. URL: https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview/ [Accessed 2026-01-31]
- Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. Mar 5, 2019;321(9):844-845. [CrossRef] [Medline]
- Issue brief: the role of HIV self-testing in ending the HIV epidemic. Centers for Disease Control and Prevention; 2022. URL: https://stacks.cdc.gov/view/cdc/129025/cdc_129025_DS1.pdf [Accessed 2026-02-5]
- HIV surveillance special report: 2019; no. 28. Centers for Disease Control and Prevention; Aug 1, 2021. URL: https://stacks.cdc.gov/view/cdc/149116 [Accessed 2026-01-31]
- Issue brief: HIV and transgender communities. Centers for Disease Control and Prevention; 2024. URL: https://stacks.cdc.gov/view/cdc/129026/cdc_129026_DS1.pdf [Accessed 2026-01-31]
- Estimated HIV incidence and prevalence in the United States, 2010–2016. Centers for Disease Control and Prevention; 2019. URL: https://stacks.cdc.gov/view/cdc/129019/cdc_129019_DS2.pdf [Accessed 2026-01-31]
- HIV surveillance supplemental report: estimated HIV incidence and prevalence in the United States, 2018–2022. Centers for Disease Control and Prevention; May 21, 2024. URL: https://stacks.cdc.gov/view/cdc/156513 [Accessed 2026-01-31]
- Myers JE, Braunstein SL, Xia Q, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. Jun 2018;5(6):ofy097. [CrossRef] [Medline]
- Hibbert MP, Wolton A, Weeks H, et al. Psychosocial and sexual factors associated with recent sexual health clinic attendance and HIV testing among trans people in the UK. BMJ Sex Reprod Health. Apr 2020;46(2):116-125. [CrossRef] [Medline]
- Olakunde BO, Pharr JR, Adeyinka DA, Conserve DF. Nonuptake of HIV testing among transgender populations in the United States: results from the 2015 U.S. Transgender Survey. Transgend Health. Oct 2022;7(5):430-439. [CrossRef] [Medline]
- Poteat T, Wirtz AL, Reisner S. Strategies for engaging transgender populations in HIV prevention and care. Curr Opin HIV AIDS. Sep 2019;14(5):393-400. [CrossRef] [Medline]
- Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. Feb 2014;47(1):5-16. [CrossRef] [Medline]
- Frye V, Wilton L, Hirshfied S, et al. “Just because it’s out there, people aren’t going to use it.” HIV self-testing among young, Black MSM, and transgender women. AIDS Patient Care STDS. Nov 2015;29(11):617-624. [CrossRef] [Medline]
- Adams LM, Simoni JM. The need for multi-level mitigation of medical mistrust among social network members contributing to antiretroviral treatment nonadherence in African Americans living with HIV: comment on Bogart et al. (2016). Soc Sci Med. Jun 2016;159:58-60. [CrossRef] [Medline]
- Witzel TC, Wright T, McCabe L, et al. Impact and acceptability of HIV self-testing for trans men and trans women: a mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales. EClinicalMedicine. Feb 2021;32:100700. [CrossRef] [Medline]
- Van Gerwen OT, Austin EL, Bethune CW, Sullivan PS, Muzny CA. Sexual healthcare and at-home STI test collection: attitudes and preferences of transgender women in the Southeastern United States. Front Public Health. 2023;11:1187206. [CrossRef] [Medline]
- Arnold EA, Rebchook GM, Kegeles SM. “Triply cursed”: racism, homophobia and HIV-related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young Black gay men. Cult Health Sex. Jun 2014;16(6):710-722. [CrossRef] [Medline]
- Poteat T, German D, Flynn C. The conflation of gender and sex: gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016;11(7-8):835-848. [CrossRef] [Medline]
- Rocha GM, Cândido RCF, de Carvalho NP, et al. Strategies to increase HIV testing among men who have sex with men and transgender women: an integrative review. BMC Infect Dis. Apr 18, 2023;23(1):240. [CrossRef] [Medline]
- McKleroy VS, Galbraith JS, Cummings B, et al. Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Educ Prev. Aug 2006;18(4 Suppl A):59-73. [CrossRef] [Medline]
- Baumann AA, Stirman SW, Cabassa LJ. Adaptation in dissemination and implementation science. In: Brownson RC, Colditz GA, Proctor EF, editors. Dissemination and Implementation Research in Health: Translating Science to Practice. Oxford University Press; 2017:172-191. [CrossRef]
- Horvath KJ, Walker T, Mireles L, Bauermeister JA, Hightow-Weidman L, Stephenson R. A systematic review of technology-assisted HIV testing interventions. Curr HIV/AIDS Rep. Aug 2020;17(4):269-280. [CrossRef] [Medline]
- Tanner AE, Song EY, Mann-Jackson L, et al. Preliminary impact of the weCare social media intervention to support health for young men who have sex with men and transgender women with HIV. AIDS Patient Care STDS. Nov 2018;32(11):450-458. [CrossRef] [Medline]
- Reback CJ, Fletcher JB, Kisler KA. Text messaging improves HIV care continuum outcomes among young adult trans women living with HIV: text me, girl! AIDS Behav. Sep 2021;25(9):3011-3023. [CrossRef] [Medline]
- Reback CJ, Blue T, Jalali A, et al. Comparative- and cost-effectiveness research determining the optimal intervention for advancing transgender women with HIV to full viral suppression (text me, Alexis!): protocol for a randomized controlled trial. JMIR Res Protoc. Jan 23, 2025;14:e65313. [CrossRef] [Medline]
- Kuo I, Liu T, Patrick R, et al. Use of an mHealth intervention to improve engagement in HIV community-based care among persons recently released from a correctional facility in Washington, DC: a pilot study. AIDS Behav. Apr 2019;23(4):1016-1031. [CrossRef] [Medline]
- Holloway IW, Jordan SP, Dunlap SL, Ritterbusch A, Reback CJ. Leveraging social networks and technology for HIV prevention and treatment with transgender women. AIDS Educ Prev. Apr 2020;32(2):83-101. [CrossRef] [Medline]
- Arnold EM, Rotheram-Borus MJ, Christodoulou J, et al. Increasing sustained viral suppression among youth living with HIV: a randomized controlled trial of stepped care intervention. AIDS Behav. Jul 2025;29(7):2287-2298. [CrossRef] [Medline]
- MacGowan RJ, Chavez PR, Borkowf CB, et al. Effect of internet-distributed HIV self-tests on HIV diagnosis and behavioral outcomes in men who have sex with men: a randomized clinical trial. JAMA Intern Med. Jan 1, 2020;180(1):117-125. [CrossRef] [Medline]
- Dana R, Sullivan S, MacGowan RJ, et al. Engaging Black or African American and Hispanic or Latino men who have sex with men for HIV testing and prevention services through technology: protocol for the iSTAMP comparative effectiveness trial. JMIR Res Protoc. Jan 6, 2023;12:e43414. [CrossRef] [Medline]
- Sullivan PS, Stephenson R, Hirshfield S, et al. Behavioral efficacy of a sexual health mobile app for men who have sex with men: randomized controlled trial of mobile messaging for men. J Med Internet Res. Feb 2, 2022;24(2):e34574. [CrossRef] [Medline]
- Wingood GM, DiClemente RJ. The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. J Acquir Immune Defic Syndr. Mar 1, 2008;47 Suppl 1:S40-S46. [CrossRef] [Medline]
- Everhart AR, Boska H, Sinai-Glazer H, et al. “I’m not interested in research; I’m interested in services”: how to better health and social services for transgender women living with and affected by HIV. Soc Sci Med. Jan 2022;292:114610. [CrossRef] [Medline]
- Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to prep acceptability among transgender women. Glob Public Health. 2016;11(7-8):1060-1075. [CrossRef] [Medline]
- MacGowan RJ, Chavez PR, Gravens L, et al. Pilot evaluation of the ability of men who have sex with men to self-administer rapid HIV tests, prepare dried blood spot cards, and interpret test results, Atlanta, Georgia, 2013. AIDS Behav. Jan 2018;22(1):117-126. [CrossRef] [Medline]
- Gender inclusive language building relationships with new clients. TransCare BC; 2022. URL: https://www.transcarebc.ca/sites/default/files/2024-03/Gender_Inclusive_Language_General.pdf [Accessed 2026-01-31]
- Bauer GR, Braimoh J, Scheim AI, Dharma C. Transgender-inclusive measures of sex/gender for population surveys: mixed-methods evaluation and recommendations. PLoS One. 2017;12(5):e0178043. [CrossRef] [Medline]
- Peitzmeier SM, Hughto JMW, Potter J, Deutsch MB, Reisner SL. Development of a novel tool to assess intimate partner violence against transgender individuals. J Interpers Violence. Jun 2019;34(11):2376-2397. [CrossRef] [Medline]
- Maksut JL, Sanchez TH, Wiginton JM, et al. Gender identity and sexual behavior stigmas, severe psychological distress, and suicidality in an online sample of transgender women in the United States. Ann Epidemiol. Dec 2020;52:15-22. [CrossRef] [Medline]
- Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. J Clin Epidemiol. Jan 1999;52(1):19-26. [CrossRef] [Medline]
- Adams N, Pearce R, Veale J, et al. Guidance and ethical considerations for undertaking transgender health research and institutional review boards adjudicating this research. Transgend Health. 2017;2(1):165-175. [CrossRef] [Medline]
- Tebbe EA, Budge SL. Research with trans communities: applying a process-oriented approach to methodological considerations and research recommendations. Couns Psychol. Oct 2016;44(7):996-1024. [CrossRef]
- Lee JJ, Cruz Y, Aguirre J, et al. Adaptation of an evidence-based HIV prevention intervention to address the needs of transgender Latina women. Transgend Health. Sep 12, 2024. [CrossRef] [Medline]
- Kuhns LM, Hereth J, Garofalo R, et al. A uniquely targeted, mobile app-based HIV prevention intervention for young transgender women: adaptation and usability study. J Med Internet Res. Mar 31, 2021;23(3):e21839. [CrossRef] [Medline]
- MacDonell KK, Wang B, Phanuphak N, et al. Optimizing an mHealth intervention to improve uptake and adherence to HIV pre-exposure prophylaxis in young transgender women: protocol for a multi-phase trial. JMIR Res Protoc. May 19, 2022;11(5):e37659. [CrossRef] [Medline]
- Mobile fact sheet. Pew Research Center. 2025. URL: https://www.pewresearch.org/internet/fact-sheet/mobile/ [Accessed 2026-01-31]
- Katz-Wise SL, Sansfaçon AP, Bogart LM, et al. Lessons from a community-based participatory research study with transgender and gender nonconforming youth and their families. Action Res (Lond). Jun 2019;17(2):186-207. [CrossRef] [Medline]
- Singh AA, Richmond K, Burnes TR. Feminist participatory action research with transgender communities: fostering the practice of ethical and empowering research designs. Int J Transgend. Jul 2013;14(3):93-104. [CrossRef]
- Andrasik MP, Yoon R, Mooney J, et al. Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials. Prev Sci. Jun 2014;15(3):268-276. [CrossRef] [Medline]
- Mann-Jackson L, Alonzo J, Garcia M, et al. Using community-based participatory research to address STI/HIV disparities and social determinants of health among young GBMSM and transgender women of colour in North Carolina, USA. Health Soc Care Community. Sep 2021;29(5):e192-e203. [CrossRef] [Medline]
- Martin JI, Meezan W. Applying ethical standards to research and evaluations involving lesbian, gay, bisexual, and transgender populations. J Gay Lesbian Soc Serv. Apr 2003;15(1-2):181-201. [CrossRef]
Abbreviations
| ADAPT-ITT: Assessment, Decision, Adaptation, Production, Topical Experts, Integration, Training, and Testing |
| HIVST: HIV self-test |
| iSTAMP: Implementation of Rapid HIV Self-Testing Among MSM Project |
| MSM: men who have sex with men |
| PrEP: pre-exposure prophylaxis |
| SME: subject matter expert |
| STI: sexually transmitted infection |
Edited by Javad Sarvestan; submitted 02.Apr.2025; peer-reviewed by Drew Westmoreland; final revised version received 16.Dec.2025; accepted 17.Dec.2025; published 20.Feb.2026.
Copyright© Joanna A Caldwell, Ruth Dana, Irah L Lucas, Patrick Sean Sullivan, Evelyn Olansky, Stephen Sullivan, Marissa Hannah, Travis Sanchez, Lisa Hightow-Weidman, Akshay Sharma. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 20.Feb.2026.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.

